Literature DB >> 19762403

Pulmonary hypertension in polymyositis-dermatomyositis: clinical and hemodynamic characteristics and response to vasoactive therapy.

O A Minai1.   

Abstract

The increased incidence of pulmonary hypertension and its association with decreased survival is well-recognised in patients with systemic sclerosis. This association is not widely appreciated in patients with polymyositis-dermatomyositis. We report clinical and hemodynamic characteristics and response to vasoactive therapy in three patients with polymyositis-dermatomyositis and pulmonary hypertension and discuss them in light of the available literature.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19762403     DOI： 10.1177/0961203309102822

Source DB:  PubMed          Journal:  Lupus        ISSN： 0961-2033            Impact factor:   2.911


  8 in total

1.  Interstitial Lung Disease in Idiopathic Inflammatory Myopathy.

Authors:  Lesley Ann Saketkoo; Dana P Ascherman; Vincent Cottin; Lisa Christopher-Stine; Sonye K Danoff; Chester V Oddis
Journal:  Curr Rheumatol Rev       Date:  2010-05

2.  Interstitial lung disease in classic and skin-predominant dermatomyositis: a retrospective study with screening recommendations.

Authors:  Pamela A Morganroth; Mary Elizabeth Kreider; Joyce Okawa; Lynne Taylor; Victoria P Werth
Journal:  Arch Dermatol       Date:  2010-07

3.  Pulmonary hypertension in polymyositis.

Authors:  Han Wang; Tao Liu; Ying-ying Cai; Lian Luo; Meng Wang; Mengmeng Yang; Lin Cai
Journal:  Clin Rheumatol       Date:  2015-10-14       Impact factor: 2.980

Review 4.  Pulmonary hypertension in rheumatic diseases: epidemiology and pathogenesis.

Authors:  Anupama Shahane
Journal:  Rheumatol Int       Date:  2013-01-19       Impact factor: 2.631

5.  Pulmonary arterial hypertension, a novelty in idiopathic inflammatory myopathies: insights and first experiences with vasoactive therapy.

Authors:  Kavish J Bhansing; Anton Vonk-Noordegraaf; Frank Pt Oosterveer; Piet Lcm van Riel; Madelon C Vonk
Journal:  RMD Open       Date:  2017-06-09

6.  Pulmonary hypertension in parenchymal lung disease.

Authors:  Iraklis Tsangaris; Georgios Tsaknis; Anastasia Anthi; Stylianos E Orfanos
Journal:  Pulm Med       Date:  2012-10-10

7.  Investigation into the cause of mortality in 49 cases of idiopathic inflammatory myopathy: A single center study.

Authors:  Yizhi Xiao; Xiaoxia Zuo; Yunhui You; Hui Luo; Liping Duan; Weiru Zhang; Yisha Li; Yanli Xie; Yaou Zhou; Wangbin Ning; Tong Li; Sijia Liu; Honglin Zhu; Ying Jiang; Siyao Wu; Hongjun Zhao
Journal:  Exp Ther Med       Date:  2016-01-18       Impact factor: 2.447

Review 8.  Pulmonary arterial hypertension in idiopathic inflammatory myopathies: Data from the French pulmonary hypertension registry and review of the literature.

Authors:  Sébastien Sanges; Cécile M Yelnik; Olivier Sitbon; Olivier Benveniste; Kuberaka Mariampillai; Mathilde Phillips-Houlbracq; Christophe Pison; Christophe Deligny; Jocelyn Inamo; Vincent Cottin; Luc Mouthon; David Launay; Marc Lambert; Pierre-Yves Hatron; Laurence Rottat; Marc Humbert; Eric Hachulla
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.